S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/RTW Investments/Q2 2020

RTW Investments

Periodo: Q2 2020 Β· Depositato: 2020-08-14
Vedi su SEC EDGAR β†—
AUM
$3.55B
Valore totale del portafoglio
Posizioni
77
Titoli dichiarati
Prima Posizione
RCKT
9.9% $351.9M
Var. Trimestrali
+8 / -5
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2020-08-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
RCKTRocket Pharmaceuticals Inc$351.9M9.90%$20.93$3.84-81.7%
9.9%
ALNYAlnylam Pharmaceuticals Inc$249.1M7.01%$148.11$312.78+111.2%
7.0%
PTCTPTC Therapeutics Inc$201.1M5.66%$50.74$83.31+64.2%
5.7%
DRNADicerna Pharmaceuticals Inc$181.7M5.11%β€”β€”
5.1%
ADVMAdverum Biotechnologies Inc$141.8M3.99%β€”β€”
4.0%
IMVTImmunovant Inc$139.2M3.92%$24.35$38.79+59.3%
3.9%
AXSMAxsome Therapeutics Inc$136.4M3.84%$82.28$244.31+196.9%
3.8%
MRTXMirati Therapeutics Inc$124.2M3.49%β€”β€”
3.5%
RNAMAvidity Biosciences Inc$103.9M2.92%β€”β€”
2.9%
MYOKMyokardia Inc$90.5M2.55%β€”β€”
2.5%
MASIMasimo Corp$88.6M2.49%$227.99β€”
2.5%
STOKStoke Therapeutics Inc$84.5M2.38%$23.83$32.70+37.2%
2.4%
BAXBaxter Intl Inc$83.5M2.35%$76.83$22.65-70.5%
2.4%
CERNCerner Corp$81.0M2.28%β€”β€”
2.3%
NTRANatera Inc$76.2M2.14%$49.86$279.32+460.2%
2.1%
TBIOTranslate Bio Inc$66.6M1.87%β€”$0.05
1.9%
RLMDRelmada Therapeutics Inc$66.3M1.86%$44.75$6.28-86.0%
1.9%
AXNXAxonics Modulation Technolog$66.1M1.86%β€”β€”
1.9%
FIXXHomology Medicines Inc$66.1M1.86%β€”β€”
1.9%
BLUBellus Health Inc New$61.5M1.73%β€”β€”
1.7%
PTGXProtagonist Therapeutics Inc$59.8M1.68%$17.66$131.62+645.3%
1.7%
TNDMTandem Diabetes Care Inc$59.2M1.67%$98.92$15.32-84.5%
1.7%
TXG10x Genomics Inc$56.8M1.60%$89.31$39.01-56.3%
1.6%
OYSTOyster Pt Pharma Inc$55.1M1.55%β€”β€”
1.6%
VCELVericel Corp$53.2M1.50%$13.82$46.98+239.9%
1.5%
AGENAgenus Inc$50.6M1.42%$77.13$3.49-95.5%
1.4%
FREQFrequency Therapeutics Inc$50.3M1.41%β€”β€”
1.4%
ESTAEstablishment Labs Hldgs Inc$43.3M1.22%$18.68$89.25+377.8%
1.2%
AVDLXXXXAvadel Pharmaceuticals plc$42.9M1.21%β€”β€”
1.2%
DMTKQDermTech Inc$37.8M1.06%β€”β€”
1.1%

AttivitΓ  Trimestre su Trimestre

Q2 2020 vs. Q1 2020

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
RNAMAvidity Biosciences Inc$103.9M
BAXBaxter Intl Inc$83.5M-70.5%
CERNCerner Corp$81.0M
MGNXMacroGenics Inc$34.8M
CLDXCelldex Therapeutics Inc New$33.9M
ISEEIVERIC bio Inc$33.6M
ADAPYAdaptimmune Therapeutics PLC$26.0M
OSUROraSure Technologies Inc$17.9M

Posizioni Chiuse (5)

TickerEmittenteNozionale
BMYBristol-Myers Squibb Co$94.0M
ZBHZimmer Biomet Holdings Inc$67.9M
SRPTSarepta Therapeutics Inc$51.8M
GBTGlobal Blood Therapeutics In$36.8M
Vivus Inc 4.5 05/01/2020$3.0M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
TXG10x Genomics Inc$45.0M+234.6%-56.3%
OYSTOyster Pt Pharma Inc$21.2M+96.9%
AXSMAxsome Therapeutics Inc$74.5M+57.5%+196.9%
RLMDRelmada Therapeutics Inc$32.7M+50.4%-86.0%
CTMXCytomx Therapeutics Inc$4.4M+42.0%
TNDMTandem Diabetes Care Inc$30.7M+35.0%-84.5%
ODTCOdonate Therapeutics Inc$10.3M+31.4%
IMVTImmunovant Inc$73.3M+29.2%+59.3%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
STAASTAAR Surgical Co$-2.8M-54.3%
ARVNArvinas Inc$-8.1M-49.5%
WVEWAVE Life Sciences Ltd$-6.9M-29.5%
VCELVericel Corp$12.3M-13.7%+239.9%
NSTGQNanoString Technologies Inc$2.3M-10.6%
AGENAgenus Inc$18.5M-1.8%-95.5%
FIXXHomology Medicines Inc$-2.3M-1.1%
XGNExagen Inc$-4.4M+0.0%
← Torna agli Hedge Fund
RTW Investments Q2 2020 13F Filing β€” Holdings & Portfolio | MarketsFN